Suchergebnisse - "Fakih, Marwan G"

PubPharm (7)

1

Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer

enthalten in: Clinical colorectal cancer | 2012

von Carneiro, B. | Ramanathan, R. | Fakih, M. | +9

2

Does celecoxib have a role in the treatment of patients with colorectal cancer?

enthalten in: Clinical colorectal cancer | 2009

von Fakih, M. | Rustum, Y.

3

Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer

enthalten in: Clinical colorectal cancer | 2007

von Puthillath, A. | Dunn, K. | Rajput, A. | +6

4

Increased frequency of uridine diphosphate glucuronosyltransferase 1A1 7/7 in patients experiencing severe irinotecan-induced toxicities

enthalten in: Clinical colorectal cancer | 2007

von Fakih, M. | Ross, M. | Starostik, P.

5

Reversible grade 4 hyperbilirubinemia in a patient with UGT1A1 7/7 genotype treated with irinotecan and cetuximab

enthalten in: Clinical colorectal cancer | 2007

von Gupta, B. | LeVea, C. | Litwin, A. | +1

6

Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy

enthalten in: Clinical colorectal cancer | 2007

von Reddy, N. | Yu, J. | Fakih, M.

7

Cetuximab-induced hypomagnesemia in patients with colorectal cancer

enthalten in: Clinical colorectal cancer | 2006

von Fakih, M. | Wilding, G. | Lombardo, J.

1
[1]